Day 1 Program

Educational Session 4: Balancing Act—Hormone Replacement Therapy in Breast Cancer Care

Day 1: December 9, 2025

2:30 PM–4:15 PM CST

Hemisfair 1-2

Session Details

The session explores the evolution of evidence and guidelines for HRT, addressing myths, current recommendations from major societies, and tailored considerations for high-risk individuals, survivors, and various breast cancer subtypes.

Moderator

Tana Sanft, Yale Cancer Center, New Haven, CT

ED4-01

Beyond hot flashes: Addressing unmet needs in menopause care after breast cancer

Maryam Blm Lustberg, Yale School of Medicine, New Haven, CT

ED4-02

Menopausal hormonal therapy after breast cancer: where do we stand today?

Lisa Larkin, Ms.Medicine, Cincinnati, OH

ED4-03

Addressing symptoms related to Genitourinary Syndrome of Menopause with low dose estrogens in women after breast cancer: What does the data show about safety?

Juliana M Kling, Mayo Clinic, Scottsdale, AZ

ED4-04

Rethinking menopause and breast cancer: is it time to change practice?

Maryam Lustberg, Yale School of Medicine, New Haven, CT

Advocate

Thelma P. Brown, Thelma Brown (Individual), Birmingham, AL